Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Ra Pharmaceuticals Is Skyrocketing Today

TheMotleyFool

0 0

Why Ra Pharmaceuticals Is Skyrocketing TodayPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

Shares of Ra Pharmaceuticals (NASDAQ: RARX), a clinical-stage biopharmaceutical company focused on rare diseases, jumped 101% as of 10:56 a.m. EST on Thursday. The huge move is a response to the news that Ra has agreed to be acquired by UCB (NASDAQOTH: UCBJF), a global biopharmaceutical company based in Belgium.

Here are the key terms of the acquisition:

Image source: Getty Images.

Source Fool.com

Like: 0

RARX

Share